The outcome of patients with acute myocardial infarction ineligible for thrombolytic therapy

American Journal of Medicine

Volumn 101, Issue 2, 1996, Pages 184-191

  Behar, Solomon ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; STREPTOKINASE;

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG SAFETY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 16044368833     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)80075-1     Document Type: Article

References (2)

1. Gruppo Italiano per lo Studio Delia Streptochinasi Nell'infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987;2:871-874.
2. AIMS Trial Study Group. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet. 1990;335:427-431.